Experience

  • Decibel on its $160 Million Agreement to Sell to Medallia Inc. 

  • Jazz Pharmaceuticals Acquisition of Redx Pharma's pan-RAF Inhibitor Program Valued up to $206 Million 

contact

+44 (0) 20 7556 4465 office
sakram@cooley.com

22 Bishopsgate
London, UK EC2N 4BQ